EDAP TMS S.A. (FOCL)
NASDAQ: FOCL · Real-Time Price · USD
5.99
-0.16 (-2.60%)
Jul 28, 2026, 2:19 PM EDT - Market open
EDAP TMS Employees
EDAP TMS had 289 employees as of December 31, 2025. The number of employees decreased by 21 or -6.77% compared to the previous year.
Employees
289
Change (1Y)
-21
Growth (1Y)
-6.77%
Revenue / Employee
$256,304
Profits / Employee
-$106,869
Market Cap
224.52M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 289 | -21 | -6.77% |
| Dec 31, 2024 | 310 | 3 | 0.98% |
| Dec 31, 2023 | 307 | 43 | 16.29% |
| Dec 31, 2022 | 264 | 37 | 16.30% |
| Dec 31, 2021 | 227 | 4 | 1.79% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Cardinal Health | 57,700 |
| Cencora | 51,000 |
| McKesson | 43,000 |
| Henry Schein | 25,000 |
| Accendra Health | 6,500 |
| 111, Inc. | 1,063 |
| Cosmos Health | 163 |
| Synergy CHC | 28 |
FOCL News
- 11 days ago - FocalTherics initiated with an Outperform at Mizuho - TheFly
- 4 weeks ago - FocalTherics™ Announces Successful Launch of First Commercial Endometriosis Focal One® Program in Europe with Treatment of Initial Patients - GlobeNewsWire
- 5 weeks ago - FocalTherics initiated with a Buy at Lucid Capital - TheFly
- 6 weeks ago - FocalTherics™ Expands Access to Focal One® Robotic HIFU for Veterans with Prostate Cancer through Agreement with MellingMedical - GlobeNewsWire
- 7 weeks ago - EDAP TMS Transcript: Jefferies Global Healthcare Conference 2026 - Transcripts
- 2 months ago - EDAP TMS Transcript: Investor Day 2026 - Transcripts
- 2 months ago - EDAP TMS Slides: FY 2026 - Filings
- 2 months ago - EDAP Announces Corporate Name Change to FocalTherics™ to Reflect Exclusive Focus on High-Growth Robotic Focal Therapy - GlobeNewsWire